Role of tachykinins in castor oil diarrhoea in rats
- 1 May 1997
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 121 (3) , 375-380
- https://doi.org/10.1038/sj.bjp.0701130
Abstract
We set out to ascertain the role of tachykinins, neurokinin A and substance P, in castor oil-induced diarrhoea in rats as disclosed by the inhibitory effect of the non-peptide NK1- and NK2-receptor antagonists, SR 140333 and SR 48968, respectively. SR 48968 (0.02 to 20 μg kg−1, s.c. or p.o.), and the opioid receptor agonist loperamide (1–10 mg kg−1, p.o.), dose-dependently prevented castor oil effects: % inhibition vs castor oil, diarrhoea 0 to 100, increase in faecal mass 7 to 90 and water content 16 to 90. SR 140333 (0.02 to 20 μg kg−1, s.c.) and the platelet activating factor antagonist SR 27417 (5 to 500 μg kg−1, p.o.) did not prevent the increase in faecal water content, but reduced faecal mass (35 to 66%) and diarrhoea (0 to 57%). The R-enantiomers of tachykinin NK1 and NK2 receptor antagonists, SR 140603 and SR 48605 (both at 2 or 20 μg kg−1, s.c.) had no effect other than reducing faecal mass at the highest dose tested. SR 48968 (20 μg kg−1, p.o.) but not loperamide (10 mg kg−1, p.o.) given 24 h before castor oil, still slightly but significantly reduced by 30% the increase of faecal mass output; both treatments significantly reduced (30 to 70%) the effect of castor oil on faecal water content, although the incidence of diarrhoea was only slightly less than in controls. In castor oil-treated rats, naloxone (2 mg kg−1, s.c.) completely blocked the antidiarrhoeal action of loperamide (10 mg kg−1, p.o.) but not of SR 48968 (20 μg kg−1, p.o.); a similar result was obtained on faecal mass and water content. Castor oil strongly increased the occurrence of manometrically recorded propulsive giant contractions (500 to 1000% over control values) of transverse and distal colon, this effect being significantly prevented (80 to 100%) by SR 48968 and loperamide and partially by SR 140333 (35% distal colon, 70% transverse colon). In castor oil free rats, loperamide but not SR 48968 or SR 140333 significantly reduced by 50% the gastrointestinal transit of a charcoal test meal, as well as 24 h faecal mass output. Consistently, loperamide, unlike the tachykinin receptor antagonists, had a dramatic effect on manometric recordings of intestinal motility, reducing all kinds of colonic contractions. Our findings suggest that castor oil diarrhoea in rats entails activation of NK1 and NK2 receptors by endogenous tachykinins, whose antagonists may have a potential as antidiarrhoeal agents free from the constipating action of opioids.Keywords
This publication has 21 references indexed in Scilit:
- Neurokinin A (NK2) receptor revisited with SR 48968, a potent non-peptide antagonistPublished by Elsevier ,2005
- Implication of NK1 and NK2 receptors in rat colonic hypersecretion induced by interleukin 1β: Role of nitric oxideGastroenterology, 1995
- Cellular sites of expression of the neurokinin‐1 receptor in the rat gastrointestinal tractJournal of Comparative Neurology, 1995
- In vitro characterizat of the non-peptide tachykinin NK1 and NK2-receptor antagonists, SR140333 and SR48968 in different rat and guinea-pig intestinal segmentsLife Sciences, 1994
- Manometric patterns of rat colonic motor activity and defecationDigestive Diseases and Sciences, 1994
- SR 48968 selectively prevents faecal excretion following activation of tachykinin NK2 receptors in ratsJournal of Pharmacy and Pharmacology, 1994
- Time Course of PAF Formation by Gastrointestinal Tissue in Rats After Castor Oil ChallengeJournal of Pharmacy and Pharmacology, 1992
- NK2 tachykinin receptors and contraction of circular muscle of the human colon: characterization of the NK2 receptor subtypeEuropean Journal of Pharmacology, 1991
- Versatile Software System for Analysis of Gastrointestinal Pressure RecordingsDigestive Diseases, 1991
- Extension of Multiple Range Tests to Group Means with Unequal Numbers of ReplicationsPublished by JSTOR ,1956